Mechanical circulatory support pathways that maximize post-heart transplant survival

Area of Science:

• Cardiology
• Transplantation Medicine
• Mechanical Circulatory Support

Background:

• Heart transplant (HTx) recipients utilize diverse support pathways, including transitions between them.
• Outcomes for patients bridged to HTx via various support pathways require clarification.
• Identifying mechanical circulatory support pathways that enhance post-HTx survival is crucial.

Purpose of the Study:

• To identify mechanical circulatory support pathways that maximize survival after heart transplantation.
• To compare post-HTx survival rates among different initial and transitional support pathways.

Main Methods:

• Utilized a supplemented United Network for Organ Sharing Dataset (2000-2010) for status 1 HTx outcomes.
• Grouped recipients by pre-HTx support pathway, including pathway transitions.
• Employed Cox proportional hazard regression to identify factors influencing time-related death.

Main Results:

• Left ventricular assist device (LVAD) use was associated with improved post-HTx survival (HR 0.71).
• Other pathways like inotropes, right ventricular assist device, and extracorporeal membrane oxygenation (ECMO) increased post-HTx death risk.
• Transitioning from ECMO or biventricular assist device to LVAD-only support improved survival, comparable to continuous LVAD therapy.

Conclusions:

• LVAD-supported HTx recipients demonstrate superior post-transplant survival compared to other mechanical support pathways.
• Optimizing HTx survival involves transitioning patients from ECMO or biventricular assist device to LVAD-only support.
• Findings can guide clinical decisions and organ allocation policies to maximize HTx benefits.